184 related articles for article (PubMed ID: 24849933)
1. Mild reduction of plasmalogens causes rhizomelic chondrodysplasia punctata: functional characterization of a novel mutation.
Noguchi M; Honsho M; Abe Y; Toyama R; Niwa H; Sato Y; Ghaedi K; Rahmanifar A; Shafeghati Y; Fujiki Y
J Hum Genet; 2014 Jul; 59(7):387-92. PubMed ID: 24849933
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of novel mutations in GNPAT and AGPS, causing rhizomelic chondrodysplasia punctata (RCDP) types 2 and 3.
Itzkovitz B; Jiralerspong S; Nimmo G; Loscalzo M; Horovitz DD; Snowden A; Moser A; Steinberg S; Braverman N
Hum Mutat; 2012 Jan; 33(1):189-97. PubMed ID: 21990100
[TBL] [Abstract][Full Text] [Related]
3. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor.
Purdue PE; Zhang JW; Skoneczny M; Lazarow PB
Nat Genet; 1997 Apr; 15(4):381-4. PubMed ID: 9090383
[TBL] [Abstract][Full Text] [Related]
4. Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.
Malheiro AR; da Silva TF; Brites P
J Inherit Metab Dis; 2015 Jan; 38(1):111-21. PubMed ID: 25432520
[TBL] [Abstract][Full Text] [Related]
5. Expanding the genotypic and phenotypic landscapes of rhizomelic chondrodysplasia punctata type 3 (RCDP3) with two novel families, and a review of the literature.
İli EG; Gezdirici A; Di Pietro E; Yergeau C; Braverman N
Am J Med Genet A; 2022 Nov; 188(11):3229-3235. PubMed ID: 35986576
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor.
Wood PL; Khan MA; Smith T; Ehrmantraut G; Jin W; Cui W; Braverman NE; Goodenowe DB
Lipids Health Dis; 2011 Oct; 10():182. PubMed ID: 22008564
[TBL] [Abstract][Full Text] [Related]
7. Defective lipid remodeling of GPI anchors in peroxisomal disorders, Zellweger syndrome, and rhizomelic chondrodysplasia punctata.
Kanzawa N; Shimozawa N; Wanders RJ; Ikeda K; Murakami Y; Waterham HR; Mukai S; Fujita M; Maeda Y; Taguchi R; Fujiki Y; Kinoshita T
J Lipid Res; 2012 Apr; 53(4):653-63. PubMed ID: 22253471
[TBL] [Abstract][Full Text] [Related]
8. Growth charts for individuals with rhizomelic chondrodysplasia punctata.
Duker AL; Niiler T; Eldridge G; Brereton NH; Braverman NE; Bober MB
Am J Med Genet A; 2017 Jan; 173(1):108-113. PubMed ID: 27616591
[TBL] [Abstract][Full Text] [Related]
9. Rhizomelic chondrodysplasia punctata, a peroxisomal biogenesis disorder caused by defects in Pex7p, a peroxisomal protein import receptor: a minireview.
Purdue PE; Skoneczny M; Yang X; Zhang JW; Lazarow PB
Neurochem Res; 1999 Apr; 24(4):581-6. PubMed ID: 10227689
[TBL] [Abstract][Full Text] [Related]
10. A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform.
Barøy T; Koster J; Strømme P; Ebberink MS; Misceo D; Ferdinandusse S; Holmgren A; Hughes T; Merckoll E; Westvik J; Woldseth B; Walter J; Wood N; Tvedt B; Stadskleiv K; Wanders RJ; Waterham HR; Frengen E
Hum Mol Genet; 2015 Oct; 24(20):5845-54. PubMed ID: 26220973
[TBL] [Abstract][Full Text] [Related]
11. A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.
Braverman N; Zhang R; Chen L; Nimmo G; Scheper S; Tran T; Chaudhury R; Moser A; Steinberg S
Mol Genet Metab; 2010 Apr; 99(4):408-16. PubMed ID: 20060764
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata.
Fallatah W; Smith T; Cui W; Jayasinghe D; Di Pietro E; Ritchie SA; Braverman N
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31862688
[TBL] [Abstract][Full Text] [Related]
13. Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1.
Motley AM; Brites P; Gerez L; Hogenhout E; Haasjes J; Benne R; Tabak HF; Wanders RJ; Waterham HR
Am J Hum Genet; 2002 Mar; 70(3):612-24. PubMed ID: 11781871
[TBL] [Abstract][Full Text] [Related]
14. The importance of ether-phospholipids: a view from the perspective of mouse models.
da Silva TF; Sousa VF; Malheiro AR; Brites P
Biochim Biophys Acta; 2012 Sep; 1822(9):1501-8. PubMed ID: 22659211
[TBL] [Abstract][Full Text] [Related]
15. MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata.
Bams-Mengerink AM; Majoie CB; Duran M; Wanders RJ; Van Hove J; Scheurer CD; Barth PG; Poll-The BT
Neurology; 2006 Mar; 66(6):798-803; discussion 789. PubMed ID: 16567694
[TBL] [Abstract][Full Text] [Related]
16. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor.
Motley AM; Hettema EH; Hogenhout EM; Brites P; ten Asbroek AL; Wijburg FA; Baas F; Heijmans HS; Tabak HF; Wanders RJ; Distel B
Nat Genet; 1997 Apr; 15(4):377-80. PubMed ID: 9090382
[TBL] [Abstract][Full Text] [Related]
17. Rhizomelic chondrodysplasia punctata and cardiac pathology.
Huffnagel IC; Clur SA; Bams-Mengerink AM; Blom NA; Wanders RJ; Waterham HR; Poll-The BT
J Med Genet; 2013 Jul; 50(7):419-24. PubMed ID: 23572185
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype.
Braverman N; Chen L; Lin P; Obie C; Steel G; Douglas P; Chakraborty PK; Clarke JT; Boneh A; Moser A; Moser H; Valle D
Hum Mutat; 2002 Oct; 20(4):284-97. PubMed ID: 12325024
[TBL] [Abstract][Full Text] [Related]
19. Variant rhizomelic chondrodysplasia punctata (RCDP) with normal plasma phytanic acid: clinico-biochemical delineation of a subtype and complementation studies.
Barth PG; Wanders RJ; Schutgens RB; Staalman CR
Am J Med Genet; 1996 Mar; 62(2):164-8. PubMed ID: 8882397
[TBL] [Abstract][Full Text] [Related]
20. Non-rhizomelic and rhizomelic chondrodysplasia punctata within a single complementation group.
Motley AM; Tabak HF; Smeitink JA; Poll-The BT; Barth PG; Wanders RJ
Biochim Biophys Acta; 1996 Apr; 1315(3):153-8. PubMed ID: 8611652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
